Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05938504
What this trial is testing

Usefulness of Balanced High Protein Supplementation on Recovery and Clinical Outcomes After Chemotherapy

Who this might be right for
Colorectal Neoplasms
Daesang Wellife 154
Not applicableStudy completedNCT03895606
What this trial is testing

Prediction of Kidney Injury After Hyperthermic Intraperitoneal Chemotherapy (HIPEC)* With Machine Learning

Who this might be right for
Acute Kidney InjuryChemotherapy
Gangnam Severance Hospital 57
Testing effectiveness (Phase 2)Looking for participantsNCT06888063
What this trial is testing

Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery

Who this might be right for
Intrahepatic Bile Duct CancerIntrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Carcinoma+1 more
Erasmus Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00084487
What this trial is testing

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Who this might be right for
Extensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)WithdrawnNCT00984438
What this trial is testing

Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
University of Cincinnati
Testing effectiveness (Phase 2)Study completedNCT00828009
What this trial is testing

BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 70
Not applicableStudy completedNCT01208532
What this trial is testing

Validation Study of the Korean Version of the EORTC QLQ-HDC29

Who this might be right for
Quality of Life After Stem Cell Transplantation
Seoul National University Hospital 226
Large-scale testing (Phase 3)Active Not RecruitingNCT05445778
What this trial is testing

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
AbbVie 520
Testing effectiveness (Phase 2)Study completedNCT01511536
What this trial is testing

Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 38
Testing effectiveness (Phase 2)Study completedNCT01263171
What this trial is testing

Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery

Who this might be right for
Colorectal Cancer
Cardiff University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05092958
What this trial is testing

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

Who this might be right for
Advanced Bladder Urothelial CarcinomaAdvanced Renal Pelvis Urothelial CarcinomaAdvanced Ureter Urothelial Carcinoma+15 more
National Cancer Institute (NCI) 654
Not applicableUnknownNCT03381092
What this trial is testing

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

Who this might be right for
Invasive Breast Cancer
Peking University 348
Large-scale testing (Phase 3)Study completedNCT00132301
What this trial is testing

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

Who this might be right for
Prostate Cancer
VA Office of Research and Development 298
Large-scale testing (Phase 3)UnknownNCT05544253
What this trial is testing

Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC

Who this might be right for
Hepatocellular CarcinomaPeritoneal MetastasisHyperthymic+1 more
West China Hospital 68
Testing effectiveness (Phase 2)Study completedNCT03007407
What this trial is testing

Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy

Who this might be right for
Colorectal Cancer Metastatic
NSABP Foundation Inc 33
Not applicableStudy completedNCT03505164
What this trial is testing

The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor

Who this might be right for
Doxorubicin Adverse ReactionCardiomyopathies, SecondaryBreast Cancer
Rush University Medical Center 42
Testing effectiveness (Phase 2)Study completedNCT02303977
What this trial is testing

Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy

Who this might be right for
Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
Abramson Cancer Center at Penn Medicine 37
Early research (Phase 1)Study completedNCT00059930
What this trial is testing

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 38
Large-scale testing (Phase 3)Study completedNCT00521664
What this trial is testing

A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups

Who this might be right for
Myeloid Leukemia
Technische Universität Dresden 400
Large-scale testing (Phase 3)UnknownNCT04789434
What this trial is testing

PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT

Who this might be right for
Lymphoma, Large B-Cell, DiffuseTransplantationChemotherapy
Ruijin Hospital 94
Next Page